After many years of testing, the first of the “biological: “mAbs” was just approved: these are once per month injections to prevent migraine; the price is much less than was anticipated(6,900 per year; first 2 months free; rebates if one qualifies); short-term: very well tolerated, few side effects; long-term: unknown. https://finance.yahoo.com/news/u-fda-approves-amgen-drug-015953808.html

Subscribe To Our Weekly Newsletter

Subscribe To Our Weekly Newsletter

Get a weekly digest of our posts straight to your inbox! We promise, no spam ever.

You have Successfully Subscribed!

Pin It on Pinterest

Share This